Evotec and Centogene Expand their Collaboration to Target Gaucher Disease

Shots: The two companies will work together to research, discover, and develop therapeutic options related to the deficiency of the protein GBA which is a gene linked to Gaucher disease The collaboration will combine Evotec’s iPSC platform and drug discovery and development capabilities with Centogene’s global rare disease platform, including iPSC lines The collaboration follows […]Read More

Pfizer Collaborates with Centogene to Access its Rare Disease Data

Shots: Centogene to receive up front and will be eligible for additional research payments for any future collaboration. Pfizer to get access to CENTOGENE’s data repository, which may be used to discover and validate new therapies targeting rare diseases The companies will work together in mining the data repository and jointly agree for any research […]Read More